HYG vs XBI
iShares iBoxx High Yield Corporate Bond ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for HYG.
- • HYG pays a higher dividend yield (6.09%).
Side-by-side metrics
| Metric | HYG | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 6.09% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $17.71B | $10.92B |
YTD return | 1.01% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.65 | 1.01 |
P/E ratio | — | — |
Last price | $77.36 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
HYG top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 1.06% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About HYG
HYG (iShares iBoxx High Yield Corporate Bond ETF) is US high-yield corporate bonds. Managed by iShares, the fund carries $17.7B in assets under management, an expense ratio of 0.49%, a dividend yield of 6.09%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.